These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

954 related items for PubMed ID: 19640573

  • 21. Complications associated with the use of Port-a-Caths in patients with malignant or haematological disease: a single-centre prospective analysis.
    Heibl C, Trommet V, Burgstaller S, Mayrbaeurl B, Baldinger C, Koplmüller R, Kühr T, Wimmer L, Thaler J.
    Eur J Cancer Care (Engl); 2010 Sep; 19(5):676-81. PubMed ID: 19708941
    [Abstract] [Full Text] [Related]

  • 22. [Totally implantable venous access ports: frequency of complications and analysis of bacterial contamination after ablation].
    Barbut F, Soukouna S, Lalande V, Garcia ML, Neyme D, de Gramont A, Petit JC.
    Pathol Biol (Paris); 2004 Dec; 52(10):566-74. PubMed ID: 15596304
    [Abstract] [Full Text] [Related]

  • 23. Changing concepts in long-term central venous access: catheter selection and cost savings.
    Horattas MC, Trupiano J, Hopkins S, Pasini D, Martino C, Murty A.
    Am J Infect Control; 2001 Feb; 29(1):32-40. PubMed ID: 11172316
    [Abstract] [Full Text] [Related]

  • 24. Risk factors for catheter-related thrombosis in cancer patients.
    Tesselaar ME, Ouwerkerk J, Nooy MA, Rosendaal FR, Osanto S.
    Eur J Cancer; 2004 Oct; 40(15):2253-9. PubMed ID: 15454250
    [Abstract] [Full Text] [Related]

  • 25. Totally implantable central venous access ports. Analysis of 700 cases.
    Barbetakis N, Asteriou C, Kleontas A, Tsilikas C.
    J Surg Oncol; 2011 Nov 01; 104(6):654-6. PubMed ID: 21671465
    [Abstract] [Full Text] [Related]

  • 26. Infectious port complications are more frequent in younger patients with hematologic malignancies than in solid tumor patients.
    Samaras P, Dold S, Braun J, Kestenholz P, Breitenstein S, Imhof A, Renner C, Stenner-Liewen F, Pestalozzi BC.
    Oncology; 2008 Nov 01; 74(3-4):237-44. PubMed ID: 18716418
    [Abstract] [Full Text] [Related]

  • 27. [Insertion and management of long-term central venous devices: role of radiologic imaging techniques].
    Capaccioli L, Nistri M, Distante V, Rontini M, Manetti A, Stecco A.
    Radiol Med; 1998 Oct 01; 96(4):369-74. PubMed ID: 9972217
    [Abstract] [Full Text] [Related]

  • 28. Polyurethane versus silicone catheters for central venous port devices implanted at the forearm.
    Wildgruber M, Lueg C, Borgmeyer S, Karimov I, Braun U, Kiechle M, Meier R, Koehler M, Ettl J, Berger H.
    Eur J Cancer; 2016 May 01; 59():113-124. PubMed ID: 27023050
    [Abstract] [Full Text] [Related]

  • 29. Thrombotic complications of central venous catheters in cancer patients.
    Bona RD.
    Semin Thromb Hemost; 1999 May 01; 25(2):147-55. PubMed ID: 10357082
    [Abstract] [Full Text] [Related]

  • 30. Complication rates and outcomes of 536 implanted subcutaneous chest ports: do rates differ based on the primary operator's level of training?
    Silas AM, Perrich KD, Hoffer EK, McNulty NJ.
    Acad Radiol; 2010 Apr 01; 17(4):464-7. PubMed ID: 20060749
    [Abstract] [Full Text] [Related]

  • 31. Management of totally implantable vascular access devices in patients with cystic fibrosis.
    Dal Molin A, Gatta C, Festini F.
    Minerva Pediatr; 2009 Oct 01; 61(5):549-55. PubMed ID: 19794380
    [Abstract] [Full Text] [Related]

  • 32. Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis.
    Schwarz RE, Groeger JS, Coit DG.
    Cancer; 1997 Apr 15; 79(8):1635-40. PubMed ID: 9118051
    [Abstract] [Full Text] [Related]

  • 33. Follow-up of radiologically totally implanted central venous access ports of the upper arm: long-term complications in 127,750 catheter-days.
    Busch JD, Herrmann J, Heller F, Derlin T, Koops A, Adam G, Habermann CR.
    AJR Am J Roentgenol; 2012 Aug 15; 199(2):447-52. PubMed ID: 22826411
    [Abstract] [Full Text] [Related]

  • 34. Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study.
    Cortelezzi A, Moia M, Falanga A, Pogliani EM, Agnelli G, Bonizzoni E, Gussoni G, Barbui T, Mannucci PM, CATHEM Study Group.
    Br J Haematol; 2005 Jun 15; 129(6):811-7. PubMed ID: 15953009
    [Abstract] [Full Text] [Related]

  • 35. Peripheral infusion ports for central venous access in patients with gynecologic malignancies.
    Cunningham MJ, Collins MB, Kredentser DC, Malfetano JH.
    Gynecol Oncol; 1996 Mar 15; 60(3):397-9. PubMed ID: 8774645
    [Abstract] [Full Text] [Related]

  • 36. Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer.
    Lee AY, Levine MN, Butler G, Webb C, Costantini L, Gu C, Julian JA.
    J Clin Oncol; 2006 Mar 20; 24(9):1404-8. PubMed ID: 16549834
    [Abstract] [Full Text] [Related]

  • 37. Risk factors for central venous catheter thrombotic complications in children and adolescents with cancer.
    Revel-Vilk S, Yacobovich J, Tamary H, Goldstein G, Nemet S, Weintraub M, Paltiel O, Kenet G.
    Cancer; 2010 Sep 01; 116(17):4197-205. PubMed ID: 20533566
    [Abstract] [Full Text] [Related]

  • 38. Implanting totally implantable venous access ports in the upper arm is feasible and safe for patients with early breast cancer.
    Xu H, Chen R, Jiang C, You S, Zhu Q, Li Y, Li S, Zha X, Wang J.
    J Vasc Access; 2020 Sep 01; 21(5):609-614. PubMed ID: 31841061
    [Abstract] [Full Text] [Related]

  • 39. Clinical outcomes of totally implantable venous access port placement via the axillary vein in patients with head and neck malignancy.
    Hong S, Seo TS, Song MG, Seol HY, Suh SI, Ryoo IS.
    J Vasc Access; 2019 Mar 01; 20(2):134-139. PubMed ID: 29923460
    [Abstract] [Full Text] [Related]

  • 40. [Long-term outcomes and complications of upper arm central venous access ports].
    Ide Y, Mikami K, Murata K.
    Gan To Kagaku Ryoho; 2013 Mar 01; 40(3):331-5. PubMed ID: 23507594
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 48.